Top Canonical Pathways | Â | p-Value | Ratio | # Genes |
---|---|---|---|---|
LD + T 3D | ||||
 | Breast Cancer Regulation | 0.0017 | 0.0209 | 4 |
 | Estrogen-mediated S-phase Entry | 0.0019 | 0.0833 | 2 |
 | Molecular Mechanisms of Cancer | 0.0028 | 0.0137 | 5 |
 | Cell Cycle Checkpoint Control | 0.0094 | 0.0364 | 2 |
 | Wnt/β-catenin Sginaling | 0.0103 | 0.0178 | 3 |
LD + T 7D | ||||
 | PTEN Signaling | 0.0009 | 0.0254 | 3 |
 | AMPK Signaling | 0.0013 | 0.0224 | 3 |
 | Melanoma Signaling | 0.0030 | 0.0476 | 2 |
 | Calcium Signaling | 0.0029 | 0.0169 | 3 |
 | Antiproliferative Role | 0.0046 | 0.0317 | 2 |
LD + T 21D | ||||
 | ErbB Signaling | <0.0001 | 0.0581 | 5 |
 | Neuregulin Signaling | 0.0001 | 0.0455 | 4 |
 | ErbB2/3 Signaling | 0.0006 | 0.0526 | 3 |
 | Molecular Mechanisms of Cancer | 0.0006 | 0.0164 | 6 |
 | ErbB4 Signaling | 0.0007 | 0.0500 | 3 |
LDW | ||||
 | Melanocyte Development, Pigmentation Signaling | 0.0001 | 0.0357 | 3 |
 | CDK5 Signaling | 0.0002 | 0.0303 | 3 |
 | RAR Activation | 0.0009 | 0.0170 | 3 |
 | PPARα/RXRα Activation | 0.0010 | 0.0168 | 3 |
 | Pyridoxal 5’-phosphate Salvage Pathway | 0.0023 | 0.0313 | 2 |